Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025
May 12, 2025
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Multiple New Multi-Commodity Targets
next post
Excellent Gold Intersections Verified at Kiimala Project

Related Posts

Can Trump Fire Fed Chair Jerome Powell? Inside...

May 1, 2025

Institutional Investment

October 1, 2025

Canada Nickel’s Crawford Nickel Project Named Under Ontario’s...

January 14, 2026

A.I.S. Resources’ Saint John Copper/Gold/Antimony Project Gets TSXV...

February 14, 2026

Crypto Market Recap: Trump’s Crypto Moves Stir ECB...

February 8, 2025

Further Outstanding Metallurgical Recoveries from Theia

March 5, 2025

Harvest Gold Announces Annual General Meeting Results

June 14, 2025

China’s Sole Uranium Miner Soars in Market Debut

December 5, 2025

Group Eleven Drills Best Hole Yet at Ballywire:...

July 3, 2025

Juggernaut Exploration

January 6, 2026

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 2

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 6

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 7

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 daytradingreports.com | All Rights Reserved